Nuwellis (NUWE) EBT Margin Growth (1y) (2014 - 2026)
Nuwellis (NUWE) EBT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -287.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 772.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 233.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -464.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn | -3,073.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,073.00 |
| Dec 31, 2025 | -3,674.00 |
| Sep 30, 2025 | -7,851.00 |
| Jun 30, 2025 | -37,547.00 |
| Mar 31, 2025 | 7,482.00 |
| Dec 31, 2024 | 15,395.00 |
| Sep 30, 2024 | 23,925.00 |
| Jun 30, 2024 | -11,861.00 |
| Mar 31, 2024 | 12,197.00 |
| Dec 31, 2023 | -13,470.00 |
| Sep 30, 2023 | 4,768.00 |
| Jun 30, 2023 | -3,981.00 |
| Mar 31, 2023 | -12,290.00 |
| Dec 31, 2022 | -101,142.00 |
| Sep 30, 2022 | 9,709.00 |
| Jun 30, 2022 | -507.00 |
| Mar 31, 2022 | 3,997.00 |
| Dec 31, 2021 | 108,173.00 |
| Sep 30, 2021 | -6,082.00 |
| Jun 30, 2021 | 2,190.00 |